Table 1.
CD44 | |||
---|---|---|---|
Negative | Positive | P‐value | |
Age | |||
<60 | 28 | 13 | 0.47 |
≧60 | 38 | 24 | |
Gender | |||
Male | 16 | 31 | <0.001 |
Female | 50 | 6 | |
Nuclear grade | |||
G1, G2 | 55 | 26 | 0.12 |
G3, G4 | 11 | 11 | |
T classification | |||
T1 | 42 | 24 | 0.91 |
T2, T3, T4 | 24 | 13 |
CD44 | |||
---|---|---|---|
Negative | Positive | P‐value | |
Age | |||
<60 | 28 | 13 | 0.47 |
≧60 | 38 | 24 | |
Gender | |||
Male | 16 | 31 | <0.001 |
Female | 50 | 6 | |
Nuclear grade | |||
G1, G2 | 55 | 26 | 0.12 |
G3, G4 | 11 | 11 | |
T classification | |||
T1 | 42 | 24 | 0.91 |
T2, T3, T4 | 24 | 13 |